Showing 1291-1300 of 7167 results for "".
Tick-Tock: Manage Wait
https://practicaldermatology.com/topics/practice-management/tick-tock-manage-wait/20713/How to make waiting a more pleasant experience for patients.From the Neck Down
https://practicaldermatology.com/topics/practice-management/from-the-neck-down/20781/Exploring other uses for Allergan's KybellaGuidelines to Represent Your Dermatology Practice on Google My Business
https://practicaldermatology.com/topics/practice-management/guidelines-to-represent-your-dermatology-practice-on-google-my-business/20837/Google My Business is a powerful tool to reach out to and engage with your target audience online.Avoid Financial Gridlock when Partners Disagree
https://practicaldermatology.com/topics/practice-management/avoid-financial-gridlock-when-partners-disagree/20980/Three ideas for every group practice.Make the Most of Online Press Releases
https://practicaldermatology.com/topics/practice-management/make-the-most-of-online-press-releases/21158/Online press releases can help boost search engine optimization for your website— when done well.Facial Skincare
https://practicaldermatology.com/topics/practice-management/facial-skincare/21228/Experts share insights on cosmeceutical and neutraceutical research and trends.Recently Passed Law Clears Way for New Sunscreen Ingredients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/recently-passed-law-clears-way-for-new-sunscreen-ingredients/21232/By forcing the FDA to clear its backlog of sunscreen ingredients pending review, The Sunscreen Innovation Act is a major win for UV protection efforts.Charging Toward Stage 2 of Meaningful Use
https://practicaldermatology.com/topics/practice-management/charging-toward-stage-2-of-meaningful-use/21467/As the next stage of the Federal EHR incentive program is set to begin, the forecast remains uncertain.Weighing the Prospects of Biosimilars
https://practicaldermatology.com/columns/clinical-focus-1/weighing-the-prospects-of-biosimilars/21477/If they are found to be comparable to the “originators,” biosimilar agents may offer patients significant therapeutic benefits as well as cost efficiency.Critical Factors to Advancing Melanoma Diagnosis and Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/critical-factors-to-advancing-melanoma-diagnosis-and-treatment/22970/Dermatologists need to stay abreast of technologies for evaluation of lesions and ensure that medical oncologists within their referral network recognize the importance of clinical trials.